RNS Number : 2888H
Unbound Group PLC
26 July 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.


Unbound Group plc

("Unbound", the "Company" or the "Group")

Delayed publication of accounts and AIM Rule 15 cash shell

Delayed publication of accounts

Further to the Company's announcement on 17 July 2023, the Company's board of directors (the "Board") confirms that the publication of the Group's annual report and accounts for the year ended 5 February 2023 ("Annual Report") will be delayed and will not be published by 5 August 2023, which is the deadline pursuant to Rule 19 of the AIM Rules for Companies ("AIM Rules"). The Company continues to work with RSM UK Group LLP as auditor with a view to publishing the Annual Report as soon as reasonably practicable.

Notwithstanding the fact that trading in the Company's ordinary shares on AIM has been suspended since 07.30 a.m. on 17 July 2023 pending clarification of the Company's financial position, the Company's ordinary shares would in any event be suspended from trading on AIM with effect from 07.30 a.m. on 7 August 2023 due to the Annual Report not being published by 5 August 2023.

AIM Rule 15 cash shell

The disposal of the business and assets of the Group's main operating subsidiary, Beaconsfield Footwear Limited (in administration), which completed on 18 July 2023 as announced by the Company on that date, is deemed to be a disposal that divests the Company of all, or substantially all of its trading businesses, activities or assets (pursuant to Rule 15 of the AIM Rules). Accordingly, with effect from 18 July 2023, Unbound Group plc is regarded, pursuant to the AIM Rules, as an AIM Rule 15 cash shell with no operating business.

As an AIM Rule 15 cash shell, the Company must make an acquisition or acquisitions which constitutes a reverse takeover under AIM Rule 14 (including seeking re-admission under the AIM Rules) within six months from 18 July 2023. Alternatively, within such time period, the Company can seek to become an investing company pursuant to AIM Rule 8, which requires, inter alia, the raising of at least £6 million and the publication of an admission document. If the Company does not complete a reverse takeover under AIM Rule 14 or seek re-admission to trading on AIM as an investing company pursuant to AIM Rule 8 (either being a "Re-admission Transaction") within such six month period, the Company's ordinary shares would be suspended from trading on AIM pursuant to AIM Rule 40 (noting that the ordinary shares are already suspended from trading on AIM as detailed above). Thereafter, if a Re-admission Transaction has not been completed within a further six month period, admission to trading on AIM of the Company's ordinary shares would be cancelled.  

The Board continues to review the options available to Unbound Group plc. The Company will provide further updates as appropriate.

 

Enquiries

 

Unbound Group plc

Neil Johnson, Chairman

Ian Watson, CEO

Gavin Manson, CFO

c/o Alma PR

 

Singer Capital Markets (Nominated Adviser & Broker)

Peter Steel / Tom Salvesen / Alaina Wong / James Fischer

  +44 (0)20 7496 3000

Alma PR Limited (Financial PR)

Josh Royston / Sam Modlin / Hannah Campbell

+44 (0)20 3405 0205

unbound@almapr.co.uk

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFLDSIRFIV